XML 88 R44.htm IDEA: XBRL DOCUMENT
v3.22.4

Share of profit/loss from investments accounted for using the equity method | 12 Months Ended
--- | ---
Dec. 31, 2022
Interests In Other Entities [Abstract] |
Share of profit/loss from investments accounted for using the equity method | Share of profit/loss from investments accounted for using the equity methodThe line item Share of profit/(loss) from investments accounted for using the equity method amounted to €68 million for 2022, compared with €39 million for 2021 and €359 million for 2020 (including €343 million for the share of Regeneron profits up to and including May 29, 2020, the date on which Sanofi ceased to exercise significant influence over Regeneron: see Note D.2.).

X
- Definition Disclosure of share of profit loss of associates and joint ventures accounted for using equity method explanatory. + References No definition available. + Details
Name: | sny_DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodTextBlock
Namespace Prefix: | sny_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Interests In Other Entities [Abstract] + References No definition available. + Details
Name: | sny_InterestsInOtherEntitiesAbstract
Namespace Prefix: | sny_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration